Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L L Miller

Showing results (131-140 of 179) with videos related to

Pageof 18
Sort By:
American Journal of Public Health|January 1, 1974
The functional committee modelJ C Abdo, W J Bennet, A Brownfield, et al.
The Journal of Experimental Medicine|October 30, 2009
PERITONEAL ABSORPTION : RED CELLS LABELED BY RADIO-IRON HEMOGLOBIN MOVE PROMPTLY FROM PERITONEAL CAVITY INTO THE CIRCULATIONP F Hahn, L L Miller, F S Robscheit-Robbins, et al.
Psychopharmacology|March 16, 1977
Marijuana: effects on storage and retrieval of prose materialL L Miller, T L Cornett, D R Brightwell, et al.
Epilepsy Research|April 21, 1999
Epilepsy and seizure occurrence in a population-based sample of Virginian twins and their familiesL L Miller, J M Pellock, J G Boggs, et al.
Journal of the National Cancer Institute|August 5, 1992
Severe myelosuppression resulting from concurrent administration of granulocyte colony-stimulating factor and cytotoxic chemotherapyN J Meropol, L L Miller, E L Korn, et al.
Physical Review Letters|October 3, 2001
Parity-forbidden excitations of Sr(2)CuO(2)Cl(2) revealed by optical third-harmonic spectroscopyA B Schumacher, J S Dodge, M A Carnahan, et al.
Circulation|September 1, 1984
Extracorporeal membrane oxygenation for patients with cardiogenic shockD G Pennington, J P Merjavy, J E Codd, et al.
Anti-Cancer Drugs|December 5, 1998
Phase II study of adozelesin in untreated metastatic breast cancerM Cristofanilli, W J Bryan, L L Miller, et al.
The Journal of Experimental Medicine|October 30, 2009
CASEIN DIGESTS PARENTERALLY UTILIZED TO FORM BLOOD PLASMA PROTEINS C Madden, L J Zeldis, A D Hengerer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1992
Phase I trial of thiotepa in combination with recombinant human granulocyte-macrophage colony-stimulating factorP J O'Dwyer, F P LaCreta, R Schilder, et al.
Pageof 18

Showing results (131-140 of 179) with videos related to

Sort By:
Pageof 18
American Journal of Public Health|January 1, 1974
The functional committee modelJ C Abdo, W J Bennet, A Brownfield, et al.
The Journal of Experimental Medicine|October 30, 2009
PERITONEAL ABSORPTION : RED CELLS LABELED BY RADIO-IRON HEMOGLOBIN MOVE PROMPTLY FROM PERITONEAL CAVITY INTO THE CIRCULATIONP F Hahn, L L Miller, F S Robscheit-Robbins, et al.
Psychopharmacology|March 16, 1977
Marijuana: effects on storage and retrieval of prose materialL L Miller, T L Cornett, D R Brightwell, et al.
Epilepsy Research|April 21, 1999
Epilepsy and seizure occurrence in a population-based sample of Virginian twins and their familiesL L Miller, J M Pellock, J G Boggs, et al.
Journal of the National Cancer Institute|August 5, 1992
Severe myelosuppression resulting from concurrent administration of granulocyte colony-stimulating factor and cytotoxic chemotherapyN J Meropol, L L Miller, E L Korn, et al.
Physical Review Letters|October 3, 2001
Parity-forbidden excitations of Sr(2)CuO(2)Cl(2) revealed by optical third-harmonic spectroscopyA B Schumacher, J S Dodge, M A Carnahan, et al.
Circulation|September 1, 1984
Extracorporeal membrane oxygenation for patients with cardiogenic shockD G Pennington, J P Merjavy, J E Codd, et al.
Anti-Cancer Drugs|December 5, 1998
Phase II study of adozelesin in untreated metastatic breast cancerM Cristofanilli, W J Bryan, L L Miller, et al.
The Journal of Experimental Medicine|October 30, 2009
CASEIN DIGESTS PARENTERALLY UTILIZED TO FORM BLOOD PLASMA PROTEINS C Madden, L J Zeldis, A D Hengerer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1992
Phase I trial of thiotepa in combination with recombinant human granulocyte-macrophage colony-stimulating factorP J O'Dwyer, F P LaCreta, R Schilder, et al.
Pageof 18